Gut Microbiota Balancing Composition for Metabolic Syndrome
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for addressing metabolic syndrome focus on symptom relief rather than the underlying causes, and dietary changes often lead to adverse reactions, failing to effectively manage the condition.
Innovation Solution
A composition combining adlay, oat, buckwheat, white bean, yellow corn, red bean, soybean, yam, big jujube, peanut, lotus seed, and wolfberry, along with bitter gourd and fermentable dietary fibers and oligosaccharides, is administered to promote beneficial gut microbiota and inhibit opportunistic pathogens, thereby improving metabolic syndrome symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If drugs are used to control metabolic syndrome symptoms, then symptom relief is achieved, but the underlying cause is not addressed and disease processes continue
Solution Approach 1:
The patent extracts and addresses the root cause of metabolic syndrome by targeting gut microbiota imbalance. Instead of merely treating symptoms with drugs, the invention identifies and intervenes on the underlying microbial dysbiosis that drives metabolic syndrome pathogenesis, thereby addressing both symptoms and root cause simultaneously
Solution Approach 2:
The patent applies preliminary action by restoring gut microbiota balance before metabolic syndrome fully develops or progresses. By correcting microbial imbalance early through specific dietary interventions, the invention prevents the cascade of metabolic disruptions that would otherwise require symptomatic drug treatment
2Object-affected harmful factors
If diet composition is changed to control blood sugar or blood lipids, then specific metabolic parameters improve, but underlying causes are ignored and success is limited
Solution Approach 1:
The patent introduces gut microbiota as an intermediary mechanism between diet and metabolic outcomes. Rather than directly controlling blood sugar and lipids through dietary restrictions, the invention modifies the gut microbial ecosystem, which then mediates metabolic processes, leading to more sustainable and effective control of blood glucose and lipid levels
Solution Approach 2:
The patent changes the fundamental parameter from macronutrient composition to gut microbiota composition. By shifting focus from what we eat to what lives in our gut, the invention transforms the approach to metabolic control, using prebiotics and probiotics to modify microbial populations, which in turn regulate metabolic parameters more effectively than direct dietary manipulation
3Object-affected harmful factors
If substantial diet composition changes are made, then metabolic parameters may improve, but adverse reactions occur and long-term compliance fails
Solution Approach 1:
The patent applies partial action by making targeted, moderate modifications to diet composition rather than extreme changes. The invention uses specific prebiotic and probiotic components in optimized ratios to achieve microbiota modulation without requiring drastic dietary overhauls, making the intervention both effective and sustainable for long-term compliance
Solution Approach 2:
The patent enables self-service by allowing the gut microbiota to perform the therapeutic work. Once the microbial ecosystem is seeded with beneficial strains and provided with appropriate prebiotics, the microbiota themselves carry out the metabolic regulation, reducing the burden on patients to maintain strict dietary control and improving long-term adherence
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively increases short-chain fatty acid-producing bacteria, decreases endotoxin-producing bacteria, and alleviates metabolic syndrome symptoms, reducing body weight and improving overall health indicators.
Implementation Method 1
The composition may be capable of increasing a first gut microbiota population containing a short-chain fatty acid (SCFA)-producing bacteria
Data Source
Figure 1
AI summary
A composition includes a first composition, a second composition and a third composition. The first composition comprises edible ingredients from fruit, seeds, or other parts of plants; the second composition comprises bitter gourd, a first oligosaccharides, a first fermentable dietary fiber, or a combination thereof; and the third composition comprises a second oligosaccharides and a second fermentable dietary fiber. The composition is used for targeting and restoring structural balance of gut microbiota and relieving chronic inflammation.